日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

在美国开展的一项前瞻性、为期两年、多中心1期临床试验(OPTIC),旨在评估ixoberogene soroparvovec治疗新生血管性年龄相关性黄斑变性的安全性和有效性。

Khanani, Arshad M; Boyer, David S; Wykoff, Charles C; Regillo, Carl D; Busbee, Brandon G; Pieramici, Dante; Danzig, Carl J; Joondeph, Brian C; Major, James C Jr; Turpcu, Adam; Kiss, Szilárd

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

美国医疗保险索赔分析显示,接受玻璃体内抗VEGF注射的患者发生眼内炎的概率为:一项关于眼内炎的眼内索赔分析。

Kiss, Szilárd; Dugel, Pravin U; Khanani, Arshad M; Broder, Michael S; Chang, Eunice; Sun, Gordon H; Turpcu, Adam

Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States

美国糖尿病和糖尿病性黄斑水肿患者对医疗保健系统的利用不足

Bressler, Neil M; Varma, Rohit; Doan, Quan V; Gleeson, Michelle; Danese, Mark; Bower, Julie K; Selvin, Elizabeth; Dolan, Chantal; Fine, Jennifer; Colman, Shoshana; Turpcu, Adam

Prevalence of and risk factors for diabetic macular edema in the United States

美国糖尿病性黄斑水肿的患病率和危险因素

Varma, Rohit; Bressler, Neil M; Doan, Quan V; Gleeson, Michelle; Danese, Mark; Bower, Julie K; Selvin, Elizabeth; Dolan, Chantal; Fine, Jennifer; Colman, Shoshana; Turpcu, Adam

Erratum to: Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration

勘误:湿性年龄相关性黄斑变性一线抗血管内皮生长因子治疗模式的回顾性分析

Johnston, Stephen S; Wilson, Kathleen; Huang, Alice; Smith, David; Varker, Helen; Turpcu, Adam; Johnston, Stephen S; Wilson, Kathleen; Huang, Alice; Smith, David; Varker, Helen; Turpcu, Adam